Persistent Opioid Use High in Head, Neck Cancer Patients

FRIDAY, Jan. 11, 2019 -- Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer, according to a study recently published in Otolaryngology-Head and Neck Surgery. Jessica...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news